Quantifying atherogenic lipoproteins for lipid-lowering strategies: Consensus-based recommendations from EAS and EFLM.

Address: Herlev and Gentofte Hospital, Copenhagen University Hospital, University of Copenhagen, Denmark. Electronic address: [email protected].; Department of Laboratory Medicine, AZ St-Jan, Brugge, University of Ghent, Belgium. Electronic address: [email protected].; Herlev and Gentofte Hospital, Copenhagen University Hospital, University of Copenhagen, Denmark.; National Institute for Health and Medical Research (INSERM), and Endocrinology-Metabolism Service, Pitié-Salpetriere University Hospital, Paris, France.; Hormone Laboratory, Haukeland University Hospital, Bergen, Norway.; Institute for Laboratory Medicine, Mikrobiologie und Blutdepot, Regionale Kliniken Holding RKH GmbH, Ludwigsburg, Germany.; Institute of Medicine, Sahlgrenska Academy at Göteborg University, Wallenberg Laboratory for Cardiovascular and Metabolic Research, Sahlgrenska University Hospital, Gothenburg, Sweden.; Department of Endocrinology and prevention of cardiovascular disease, Pitié-Salpetriere University Hospital, Paris, France.; Department of Pharmacological and Biomolecular Sciences, University of Milan, and IRCCS Multimedica, Milan, Italy.; Department of Clinical Chemistry and Laboratory Medicine, Leiden University Medical Center, Leiden, the Netherlands.; Departments of Clinical Blood Sciences and Cardiology, St George's University Hospitals NHS Foundation Trust and St George's University of London, London, UK.; Department of Internal Medicine, Centres Hospitaliers Jolimont, Haine-Saint-Paul, Department of Cardiology, UCL Cliniques Universitaires Saint-Luc, Brussels, Belgium.; Department of Clinical Biochemistry, University Hospitals of North Midlands NHS Trust, Stoke-on-Trent, UK.; Institute for Clinical Chemistry, University Hospital Zurich, Zurich, Switzerland.; Kantonspital Aarau AG, Institute for Laboratory Medicine, Aarau, Switzerland.; Cardiology Department, Onassis Cardiac Surgery Center, Athens, Greece.; Department of Medical Genetics, Molecular and Clinical Pharmacology, Division of Genetic Epidemiology, Medical University of Innsbruck, Innsbruck, Austria.; Divisions of Preventive and Cardiovascular Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.; Department of Clinical Chemistry, University of Turku and Turku University Hospital, Turku, Finland.; Lipoprotein Metabolism Section, Cardiovascular-Pulmonary Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD, USA.; Boston Children's Hospital, Harvard Medical School, Boston, MA, USA.; Lipid Clinic, Department of Endocrinology and Nutrition, Institut d'Investigacions Biomèdiques August Pi Sunyer, Hospital Clínic, Barcelona and Ciber Fisiopatología de la Obesidad y Nutrición (CIBEROBN), Instituto de Salud Carlos III (ISCIII), Spain.; Center for Medical Biochemistry, Clinical Center of Serbia, Belgrade, Serbia.; Libertas International University, Zagreb, Croatia.; Dept. of Laboratory Medicine, Collegium Medicum, NC University, Bydgoszcz, Poland.; Lipid Disorders Clinic, Department of Cardiology, Royal Perth Hospital, University of Western Australia, Perth, Australia.; Department of Clinical Chemistry, HUSLAB, Helsinki University Hospital, Helsinki, Finland.